227 related articles for article (PubMed ID: 14963475)
1. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan).
Usta MF; Sanabria J; Bivalacqua TJ; Hellstrom WJ
Int J Impot Res; 2004 Feb; 16(1):73-7. PubMed ID: 14963475
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
[TBL] [Abstract][Full Text] [Related]
3. Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat.
Champion HC; Bivalacqua TJ; Wang R; Kadowitz PJ; Keefer LK; Saavedra JE; Hrabie JA; Doherty PC; Hellstrom WJ
J Urol; 1999 Jun; 161(6):2013-9. PubMed ID: 10332492
[TBL] [Abstract][Full Text] [Related]
4. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the feline erection model.
Champion HC; Wang R; Santiago JA; Murphy WA; Coy DH; Kadowitz PJ; Hellstrom WJ
J Androl; 1997; 18(5):513-21. PubMed ID: 9349749
[TBL] [Abstract][Full Text] [Related]
5. Rationale for the combination of PGE(1) and S-nitroso-glutathione to induce relaxation of human penile smooth muscle.
Angulo J; Cuevas P; Moncada I; Martín-Morales A; Allona A; Fernández A; Gabancho S; Ney P; Sáenz de Tejada I
J Pharmacol Exp Ther; 2000 Nov; 295(2):586-93. PubMed ID: 11046092
[TBL] [Abstract][Full Text] [Related]
6. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
7. Topiglan MacroChem.
McMahon CG
Curr Opin Investig Drugs; 2002 Apr; 3(4):602-6. PubMed ID: 12090731
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model.
Choi S; O'Connell L; Min K; Kim NN; Munarriz R; Goldstein I; Bischoff E; Traish AM
J Androl; 2002; 23(3):332-7. PubMed ID: 12002434
[TBL] [Abstract][Full Text] [Related]
9. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
10. Topical prostaglandin E1 SEPA gel for the treatment of erectile dysfunction.
McVary KT; Polepalle S; Riggi S; Pelham RW
J Urol; 1999 Sep; 162(3 Pt 1):726-30; discussion 730-1. PubMed ID: 10458353
[TBL] [Abstract][Full Text] [Related]
11. Feline penile erection induced by transurethral administration of sodium nitroprusside.
Bivalacqua TJ; Champion HC; Wang R; Kadowitz PJ; Doherty PC; Hellstrom WJ
Urol Res; 1999 Dec; 27(6):432-6. PubMed ID: 10651131
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction.
Goldstein I; Payton TR; Schechter PJ
Urology; 2001 Feb; 57(2):301-5. PubMed ID: 11182341
[TBL] [Abstract][Full Text] [Related]
13. [Topical therapy in erectile dysfunction].
Floth A
Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
Schultheiss D; Pilatz A; Gabouev AI; Schlote N; Wefer J; Mertsching H; Sohn M; Jonas U; Stief CG
Urology; 2004 Sep; 64(3):598-602. PubMed ID: 15351616
[TBL] [Abstract][Full Text] [Related]
15. Comparison of oral and intracavernosal vasoactive agents in penile erection.
Lue T; Goldstein I; Traish A
Int J Impot Res; 2000 Mar; 12 Suppl 1():S81-88. PubMed ID: 10845769
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
[TBL] [Abstract][Full Text] [Related]
17. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.
Peterson CA; Bennett AH; Hellstrom WJ; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC; Gesundheit N
J Urol; 1998 May; 159(5):1523-7; discussion 1527-8. PubMed ID: 9554347
[TBL] [Abstract][Full Text] [Related]
18. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
19. Topical application of a Rho-kinase inhibitor in rats causes penile erection.
Dai Y; Chitaley K; Webb RC; Lewis RW; Mills TM
Int J Impot Res; 2004 Jun; 16(3):294-8. PubMed ID: 14961052
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species.
Brugger N; Kim NN; Araldi GL; Traish AM; Palmer SS
J Sex Med; 2008 Feb; 5(2):344-56. PubMed ID: 18047485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
